Gujarat Kidney and Super Speciality Share Price | Gujarat Kidney and Super Speciality Stock Screener
GKSL
Hospitals
Share Price NSE
₹129.83
▼
-1.11 (-0.85%)
Share Price BSE
₹129.90
▼
-1.10 (-0.84%)
As of July 3, 2026, the Gujarat Kidney and Super Speciality share price (NSE: GKSL) is ₹129.83 on NSE and ₹129.90 on BSE, down 0.85% from the previous close, with shares trading between ₹129.11 and ₹131.42, and a 52-week range of ₹99.36–₹143.33.
Analyse GKSL share price charts and track historical price performance.
Use the Gujarat Kidney and Super Speciality stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Gujarat Kidney and Super Speciality Market Cap
₹1,039.55 Cr.
GKSL P/E Ratio (TTM)
60.89
Gujarat Kidney and Super Speciality P/B Ratio
4.05
EPS (TTM)
₹2.49
Dividend Yield
-
Debt to Equity
0.39
GKSL 52 Week High
₹143.33
Gujarat Kidney and Super Speciality 52 Week Low
₹99.36
Operating Margin
21.00%
Profit Margin
16.13%
GKSL Revenue (TTM)
₹31.00
EBITDA
₹7.00
Net Income
₹5.00
Total Assets
₹298.00
Total Equity
₹253.00
Gujarat Kidney and Super Speciality Share Price Chart
Screen Gujarat Kidney and Super Speciality share price with an interactive chart. Analyse GKSL price trends and volatility across different timeframes.
Gujarat Kidney and Super Speciality Company Profile - Fundamental Screener
Screen Gujarat Kidney and Super Speciality company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GKSL shares.
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
ISIN
INE0V0W01025
Gujarat Kidney and Super Speciality Balance Sheet Screener
Screen GKSL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 298 | 55 | 21 | 4 | 4 |
| Current Assets | 105 | 22 | 7 | 1 | 1 |
| Fixed Assets | 38 | 31 | 14 | 0 | 3 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 15 | 7 | 6 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 253 | 27 | 11 | 0 | 0 |
| Share Capital | 16 | 11 | 0 | 0 | 0 |
| Reserves & Surplus | 237 | 15 | 2 | 0 | 0 |
Gujarat Kidney and Super Speciality Income Statement Screener - Profit & Revenue Analysis
Screen Gujarat Kidney and Super Speciality income statement and profit fundamentals.
Analyze GKSL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Gujarat Kidney and Super Speciality share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept |
|---|---|---|---|---|---|---|---|
| Revenue | 31 | 23 | 13 | 15 | 10 | 12 | 9 |
| Expenses | 24 | 16 | 8 | 7 | 7 | 7 | 5 |
| EBITDA | 7 | 7 | 5 | 9 | 3 | 5 | 5 |
| Operating Profit % | 21.00% | 30.00% | 40.00% | 57.00% | 27.00% | 39.00% | 52.00% |
| Depreciation | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Interest | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 5 | 5 | 4 | 8 | 2 | 4 | 4 |
| Tax | 0 | 1 | 1 | 2 | 0 | 1 | 1 |
| Net Profit | 5 | 4 | 3 | 5 | 1 | 3 | 3 |
| EPS | 0.81 | 0.52 | 0.47 | 0.85 | 0.25 | 0.52 | 0.65 |
Gujarat Kidney and Super Speciality Cash Flow Screener - Liquidity Fundamentals
Screen GKSL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March |
|---|---|---|---|
| Operating Activities | 14 | 1 | 0 |
| Investing Activities | -18 | 0 | 0 |
| Financing Activities | 6 | -1 | 0 |
| Net Cash Flow | 2 | 1 | 0 |
Gujarat Kidney and Super Speciality Shareholding Pattern Screener
See Gujarat Kidney and Super Speciality shareholding pattern with promoter, FII, and DII holdings.
Check Gujarat Kidney and Super Speciality promoter holding and ownership changes for GKSL on TickJournal.
| Item | 2026-Mar | 2025-Dec | 2025-Mar |
|---|---|---|---|
| Promoter Holding | 71.45% | 71.45% | 99.10% |
| FII Holding | 4.88% | 10.47% | 0.00% |
| DII Holding | 0.56% | 1.67% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% |
| Public Holding | 10.64% | 11.57% | 0.00% |
| Other Holding | 12.46% | 4.84% | 0.90% |
| Shareholder Count | 18,301 | 7 | 7 |
Gujarat Kidney and Super Speciality Share Dividend Screener - Share Yield Analysis
Check Gujarat Kidney and Super Speciality dividend history with payout and yield data.
View Gujarat Kidney and Super Speciality dividend details including ex-dates and amounts for GKSL stock.
Gujarat Kidney and Super Speciality Stock Index Membership
See which indices include Gujarat Kidney and Super Speciality stock.
Check GKSL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Gujarat Kidney and Super Speciality Market Events Screener - Corporate Actions
Get Gujarat Kidney and Super Speciality corporate actions including splits, bonuses, and buybacks.
Check Gujarat Kidney and Super Speciality stock events that may affect GKSL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-28 | 2026-05-28 | Quarterly Result Announcement | NA | -4.88% |
| 2026-02-14 | 2026-02-14 | Quarterly Result Announcement | NA | 1.61% |
Gujarat Kidney and Super Speciality Competitors Screener - Peer Comparison
Screen GKSL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 124,633 | 62.38 | 25,229 | 14.70% | 2,032 | 71.20 |
| Max Healthcare Institute | 110,463 | 76.20 | 8,373 | 16.56% | 1,464 | 68.33 |
| Fortis Healthcare | 72,431 | 67.89 | 9,128 | 16.28% | 1,064 | 48.54 |
| Narayana Hrudayalaya | 40,504 | 49.98 | 7,896 | 41.63% | 788 | 58.91 |
| Aster DM Healthcare | 39,955 | 95.24 | 4,643 | 8.32% | 384 | 55.40 |
| Global Health | 35,681 | 63.78 | 4,410 | 16.94% | 584 | 67.55 |
| Krishna Institute of Medical Sciences | 34,837 | 141.31 | 3,905 | 27.31% | 198 | 62.26 |
| Dr. Agarwal's Health Care | 14,977 | 90.41 | 2,080 | 18.39% | 168 | 61.17 |
| Rainbow Childrens Medicare | 14,420 | 50.97 | 1,703 | 8.69% | 262 | 57.37 |
| Park Medi World | 12,835 | 47.34 | 1,679 | 17.77% | 272 | 65.02 |
Gujarat Kidney and Super Speciality Company Announcements - News Screener
Screen GKSL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-02 | Closure of Trading Window | - |
| 2026-06-04 | Notice Of Postal Ballot | - |
| 2026-06-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-30 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-29 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-28 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-28 | Financial Results As On 31.03.2026 | - |
| 2026-05-28 | Board Meeting Outcome for Announcement Of Quarterly And Annual Results For The Financial Year Ended On 31.03.2026 | - |
| 2026-05-23 | Board Meeting Intimation for Consideration And Approval Of Audited Quarterly And Yearly Financial Results And Other Matters. | - |
| 2026-05-15 | Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 | - |
| 2026-05-15 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | - |
| 2026-05-14 | GKSL Scales Up Renal Care: 100 Units AI-Powered Haemodialysis Machines To Be Inducted Across Network. First 8 Machines To Go Live At Gujarat Multi Speciality Hospital Godhra Gujarat Within 10 Days Following Completion Of All Required Inspections | - |
| 2026-04-30 | Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | - |
| 2026-04-27 | Announcement under Regulation 30 (LODR)-Acquisition | - |
| 2026-04-27 | Appointment of Company Secretary and Compliance Officer | - |
| 2026-04-25 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | - |
| 2026-04-25 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | - |
| 2026-04-20 | Intimation About Payment Of Fine Levied Under Regulation 29 Of SEBI (LODR) Regulations 2015 | - |
| 2026-04-16 | Intimation Of Receipt Of Notice For Non Compliance With Regulation 29(2)/29(3) Of SEBI (LODR) Regulations 2015 | - |